Breast Lesion Localization Market Report 2023 (Global Edition)

Global Breast Lesion Localization Market Report 2023 talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Breast Lesion Localization Industry growth. Breast Lesion Localization market has been segmented with the help of its Type, Application Technique, and others. Breast Lesion Localization market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.

Report scope is customizable as we have a huge database of Breast Lesion Localization industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.

Breast Lesion Localization Market: Type Analysis

• Wire-guided Localization

Wire-guided Localization Revenue in Breast Lesion Localization is expected to reach USD 714.51 Million by 2028.

Wire localization is a treatment that involves marking the exact site of a tumour or anomaly with a tiny wire. Preoperative histological diagnosis is possible with ultrasound-guided percutaneous biopsy or stereotactic biopsy of a breast lesion. Several approaches for detecting non-palpable breast tumours have been presented, but the wire-guided localization (WGL) technique is the most often used. Wire-guided localization (WGL) is the oldest and most extensively utilized approach for removing nonpalpable beast lesions. This method is simple to conduct under ultrasound or mammography guidance, and it allows for real-time control of the wire-needle position, allowing for precise lesion localization. 

• Radioactive Seed Localization

Preoperative localization is critical for the most effective surgical treatment of breast lesions, especially those that are not palpable. For nonpalpable breast lesions, radioactive seed localization (RSL) utilizing iodine-125 which is a relatively novel method that can be used instead of wire localization. These seeds do not move after being placed in order to offer appropriate surgical guidance. Furthermore, radioactive seed localization is a reliable preoperative localization approach for breast tumours with little seed movement, regardless of in-situ duration. It is a simple and efficient method that improves patient care coordination.

• Non-radioactive Radar Localization

Radar breast localization can assist the surgeon in pinpointing and surgically removing the breast abnormalities while sparing healthy tissue. In the aberrant breast tissue, a small metal reflector is placed. During surgery, the breast surgeon might use this reflector to target the problematic tissue. It allows radiologists to highlight regions of concern that arise on the imaging studies, allowing surgeon to remove the abnormal tissue. It combines sophisticated imaging with accurate tumour identification to remove breast tumours with the least amount of disruption to healthy breast tissue.

• Magnetic Seed

Magnetic seeds, commonly known as magseed, are a viable and safe means of locating breast lesions. It aids radiologists and surgeons in locating anomalies in the breast for tissue removal. They may be precisely inserted, show no migration, and are visible in breast tissue of various sizes and depths. Prior to operation day, magseed (the size of a grain of rice) is put into the malformation under imaging guidance. It is made up of a magnetic marker that may be identified during surgery using the probe. The magnetic seeds can be placed with a needle and guided imaging of a mammography up to 30 days before surgery.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Breast Lesion Localization Industry. Request a Free Sample PDF!

Breast Lesion Localization Market: Application Analysis

• Hospitals

Hospital's Revenue in Breast Lesion Localization is expected to reach USD 1,256.22 Million by 2028.

Individuals' primary points of diagnosis and treatment are hospitals. As a result, most hospitals employ a variety of breast lesion localization procedures to detect breast abnormalities. Similarly, hospitals have a large number of competent personnel and diagnostic procedures. The use of breast lesion localization techniques in hospitals is increasing as a result of this. Several hospitals have their own labs where modern technology can be used to identify cancers. Also, during operating procedures, breast lesion localization devices are widely employed in hospitals.

• Clinics

Clinics are also the primary location for outpatient diagnostic, therapeutic, and preventative care. Clinics employ a variety of technologies, such as breast lesion localization, to meet the needs of patients. Clinicians uses the various techniques to remove a small amount of tissue from a suspicious area for lab analysis. Some clinics have their own tie ups with lab for analysis of samples.

• Ambulatory Surgical Centers

Patient-friendly environments, specialist centres, and cost-effective treatment procedures are all present in ambulatory surgery centres. As a result, it employs a variety of breast lesion localization techniques.

The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the Breast Lesion Localization market report 2023 Edition by contacting our team.

Breast Lesion Localization Technique Segment Analysis

Breast Lesion Localization Market: Technique Analysis

• Fine Needle Aspiration

Fine Needle Aspiration Revenue in Breast Lesion Localization is projected to reach USD 607.32 Million by 2028.

FNA, also known as fine needle biopsy, is a form of biopsy in which a needle is introduced into a lump or mass to get a sample of cells. It is one of several methods for identifying breast masses other than surgical removal. Fine needle aspiration uses a technique for obtaining tissue and fluid samples from solid or cystic breast lesions using a small (21 to 25 gauge) needle. With a thin needle similar to those used for blood testing, a breast fine needle aspiration (FNA) extracts some fluid or cells from a breast lesion (a cyst, lump, sore, or swelling). A specialized doctor examines a sample of fluid or cells.

• Biopsy Core Needle

A breast lump that is visible on a mammography or ultrasound, or that doctor feels during a clinical breast exam, may be assessed with a core needle biopsy. A radiologist or surgeon removes tissue samples from the breast lump using a narrow, hollow needle. Several samples are taken and analyzed, each roughly the size of a grain of rice. The needle is either aimed directly at the location of a palpable lesion (freehand biopsy) or an imaging approach such as ultrasound-guided core needle biopsy and MRI-guided core needle biopsy is used to locate the target lesion. Core needle biopsy had a lower risk of complications than open surgical biopsy.

• Biopsy Image-guided Biopsy

Image guided biopsy is a method in which tissue samples are taken under image guidance in order to obtain a diagnosis. Sound waves are used in an ultrasound-guided breast biopsy to find a lump or abnormality and extract a tissue sample for evaluation under a microscope. It is less intrusive than surgical biopsy, leaves little to no scarring, and does not require ionizing radiation exposure. Similarly, CT-guided large-core needle biopsy has been shown to be a safe and effective way for sampling breast lesions in circumstances when traditional procedures are not viable.

• Fine Needle Aspiration
• Biopsy Core Needle
• Biopsy Image-guided Biopsy

Breast Lesion Localization Uses Segment Analysis

Breast Lesion Localization Market, by Uses

• Tumor Identification

Tumor Identification Revenue in Breast Lesion Localization is estimated to reach USD 1,305.77 Million by 2028.

Breast cancer diagnosis has evolved over the last few years. Breast lesion localisation is a cutting-edge technique for detecting benign and malignant cancers in breast images during screening and diagnosis. Breast cancer increases the need for therapeutic methods by increasing the frequency of malignant tumours in women. It aids surgeons and radiologists in the detection of tumours and also serves as a marketplace for surgical treatments.

• Sentinel Lymph Node Identification

When cancer spreads, the first lymph node to be impacted is the sentinel node. The preoperative method of identifying lymph nodes is used to eliminate the primary cancer cells. These sentinel lymph nodes were detected using breast lesion localization equipment. The modified sentinel node and occult lesion localization (SNOLL) approach, which uses a single nano colloidal radiotracer injection, has a high intraoperative sentinel lymph node identification rate

• Tumor Identification
• Sentinel Lymph Node Identification

Breast Lesion Localization Market Regional Analysis

Region and country analysis section of Breast Lesion Localization Industry Analysis has been segmented into 5 major region such as North America, Europe, Asia Pacific, Middle East & Africa ,and Latin America (along with respective major contributing countries) and provides the revenue share, current trends.

The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of Breast Lesion Localization market.

Region-wise, the market is analyzed across: (In case you wish to acquire a specific region or any country data then please contact us)

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!

The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of this market.

Company Profile:

Becton, Dickinson, and Company 

BD is a medical technology company that has adopted advancements in the manufacturing of medical devices, diagnostics, and delivery of care. The company provides innovative solutions that help advance medical research and genomics, enhance diagnosis of disease, cancer, optimizes medication management, promote infection prevention, and equip surgical and interventional procedure, supports the management of diabetes. BD Technologies and innovation in Research Triangle Park in North Carolina develop next-generation technologies including advanced diagnostics, and computer-aided engineering technology develops innovative, optimized, robust products utilizing CAE technologies, genomic sciences, smart data, and science technologies, and this increases its value in the market.

The company operates in three major business segments which include

• BD Medical

     Diabetes Care
     Medication Delivery Solutions
     Medication Management Solutions
     Pharmaceutical Systems

• BD Interventional

     Peripheral Intervention
     Surgery
     Urology and Critical Care

• BD Life Sciences

     Biosciences
     Integrated Diagnostic Solutions

News:

• March 2021

BD Acquires GSL Solutions, Inc., Broadening Medication Management Offerings for Retail, Outpatient Pharmacy Settings

BD company has acquired GSL solutions, a privately held company that developed smart medication devices for the storage and tracking of a controlled substance. and patient-specific medications that improve the security, efficiency, and compliance of medication storage, as well as analytic capabilities to further improve inventory management, including controlled substances, regulatory compliance, and patient safety.

SurgicEye GmbH

SurgicEye GmbH is a solution and service provider for nuclear medicine-guided therapies. It offers several products to healthcare professionals including declipse SPECT Open surgery, declipse SPECT imaging probe, and others. The company serves its products worldwide including Europe, the USA, Latin America, GCC, and Asia Pacific.

Top Companies Market Share in Breast Lesion Localization Industry: (In no particular order of Rank)

• D. Company
• Cianna Medical
• Cook Medical
• Becton
• Dickinson and Company 
• Endomagnetics Ltd
• Health Beacon
• Intramedicalimaging
• Devicor Medical Products Inc
• Somatex Medical Technologies GmbH
• Surgiceye GmbH
• Ranfac Corporation
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables..